Brief: GenOway FY Ebitda Up At Eur 4.6 Million

genOway SA

26/03/2024 16:54

March 26 (Reuters) - genOway SA  ALGEN.PA :
    * FY CONSOLIDATED SALES OF EUR 20.0 MILLION, ORGANIC GROWTH
OF 18%
COMPARED WITH 2022
    * FY EBITDA DE 4,6 MEUR, UP 54%
    * IMPLEMENTATION OF THE NEW ROUTE 50+ STRATEGIC PLAN IS
PROCEEDING
ACCORDING TO PLAN, WITH THE LAUNCH OF A LARGE NUMBER OF NEW
EMPLOYMENTS
    * THE 2024 FINANCIAL YEAR SHOULD BE PART OF A GROWTH DYNAMIC
SIMILAR TO 2023
    * THE COMPANY ALSO INTENDS TO WORK ON ACQUISITION PROJECTS
TO
ACCELERATE GROWTH BEYOND ITS ORGANIC TARGET OF €50M
    * AS OF DEC. 2023, CASH FLOW NET OF FINANCIAL DEBT AT LOSS
EUR
241,000, VERSUS LOSS EUR 4.16 MILLION IN DEC 2022
    * FY OPERATING PROFIT AT EUR 2.07 MILLION, VERSUS EUR
950,000 IN
2022

Source text for Eikon:  ID:nACT84748 
Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))